Renata Formánková

1.2k total citations
24 papers, 314 citations indexed

About

Renata Formánková is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Renata Formánková has authored 24 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Immunology. Recurrent topics in Renata Formánková's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Renata Formánková is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Renata Formánková collaborates with scholars based in Czechia, Germany and Netherlands. Renata Formánková's co-authors include Jan Starý, Petr Sedláček, Eva Froňková, Jan Trka, Ester Mejstříková, Lucie Šrámková, Petra Keslová, Ondřej Hrušák, Kateřina Mužíková and Ondřej Krejčí and has published in prestigious journals such as Blood, Clinical Immunology and Bone Marrow Transplantation.

In The Last Decade

Renata Formánková

23 papers receiving 311 citations

Peers

Renata Formánková
S. K. China
Nathalie Aladjidi France
M Michallet France
Meghan A. Higman United States
Petter Svenberg Sweden
Sandeep Nagra United Kingdom
R Hanada Japan
K Miyamura Japan
Irene Cavattoni Italy
Bruce Greig United States
S. K. China
Renata Formánková
Citations per year, relative to Renata Formánková Renata Formánková (= 1×) peers S. K.

Countries citing papers authored by Renata Formánková

Since Specialization
Citations

This map shows the geographic impact of Renata Formánková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Formánková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Formánková more than expected).

Fields of papers citing papers by Renata Formánková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Formánková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Formánková. The network helps show where Renata Formánková may publish in the future.

Co-authorship network of co-authors of Renata Formánková

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Formánková. A scholar is included among the top collaborators of Renata Formánková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Formánková. Renata Formánková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svatoň, Michael, Petr Sedláček, Renata Formánková, et al.. (2025). NGS‐MRD negativity in post‐HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk. HemaSphere. 9(4). e70124–e70124. 1 indexed citations
2.
Formánková, Renata, Petra Keslová, Pavel Ješina, et al.. (2022). Hematopoietic stem cell transplantation in children with inborn errors of metabolism and malignant infantile osteopetrosis. 77(5). 276–283.
3.
Keslová, Petra, Renata Formánková, Marta Šnajderová, et al.. (2020). Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood. Neoplasma. 67(5). 1164–1169. 8 indexed citations
4.
Kotrová, Michaela, Vincent H. J. van der Velden, Jacques J. M. van Dongen, et al.. (2017). Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL. Bone Marrow Transplantation. 52(7). 962–968. 58 indexed citations
5.
Pelák, Ondřej, Jan Stuchlý, Petr Hubáček, et al.. (2015). Appearance of cytomegalovirus‐specific T‐cells predicts fast resolution of viremia post hematopoietic stem cell transplantation. Cytometry Part B Clinical Cytometry. 92(5). 380–388. 14 indexed citations
6.
Froňková, Eva, Ester Mejstříková, Renata Formánková, et al.. (2008). B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL. Bone Marrow Transplantation. 42(3). 187–196. 46 indexed citations
7.
8.
Hubáček, Petr, Petra Keslová, Renata Formánková, et al.. (2008). Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatric Transplantation. 13(7). 919–922. 17 indexed citations
9.
Sedláček, Petr, Renata Formánková, Ester Mejstříková, et al.. (2007). Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen‐mismatched unrelated donors. Pediatric Transplantation. 12(1). 24–31. 4 indexed citations
10.
Janda, Aleš, Petr Sedláček, Ester Mejstříková, et al.. (2007). Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatric Transplantation. 11(4). 441–447. 23 indexed citations
11.
Šrámková, Lucie, Kateřina Mužíková, Eva Froňková, et al.. (2006). Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 48(1). 93–100. 59 indexed citations
12.
Sedláček, Petr, Renata Formánková, Petra Keslová, et al.. (2006). Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin. Bone Marrow Transplantation. 38(11). 745–750. 11 indexed citations
13.
Hubáček, Petr, Ondřej Cinek, Michal Kulich, et al.. (2006). [EBV quantification in children after allogeneic hematopoietic stem cell transplantation].. PubMed. 145(4). 301–6. 1 indexed citations
14.
Zemanová, Zuzana, K Michalová, Marie Jarošová, et al.. (2006). Clinical Relevance of Complex Chromosomal Aberrations in Bone Marrow Cells of 107 Children with ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia (ALL).. Blood. 108(11). 2278–2278. 2 indexed citations
15.
Špíšek, Radek, Ester Mejstříková, Renata Formánková, et al.. (2006). [Familial haemophagocytic lymphohistiocytosis caused by perforin deficit can be successfully treated by haematopoietic stem cell transplantation--the first diagnosed case in the Czech Republic].. PubMed. 145(1). 50–4. 2 indexed citations
16.
Formánková, Renata, Petr Sedláček, Petra Keslová, et al.. (2005). Minitransplant Using Repeated Unrelated Donor Lymphocyte Infusions as a Treatment of Immunodeficiency in Complete DiGeorge Syndrome.. Blood. 106(11). 5438–5438. 1 indexed citations
17.
Mužíková, Kateřina, Eva Froňková, Lucie Šrámková, et al.. (2005). Detectable Minimal Residual Disease before Haematopoietic Stem Cell Transplantation Predicts Extremely Poor Prognosis in Children with Acute Lymphoblastic Leukaemia.. Blood. 106(11). 2037–2037. 5 indexed citations
18.
Formánková, Renata, Petr Sedláček, Jan Starý, et al.. (2001). 6. Chimerism-directed adoptive immunotherapy in prevention and/or treatment of post-transplant relapse of leukemia in childhood. Reports of Practical Oncology & Radiotherapy. 6. S19–S20. 1 indexed citations
19.
20.
Formánková, Renata, et al.. (2000). Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia. Bone Marrow Transplantation. 25(4). 453–456. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. K. Breakdown of academic impact, for papers by Nathalie Aladjidi Breakdown of academic impact, for papers by M Michallet Breakdown of academic impact, for papers by Meghan A. Higman Breakdown of academic impact, for papers by Petter Svenberg Breakdown of academic impact, for papers by Sandeep Nagra Breakdown of academic impact, for papers by R Hanada Breakdown of academic impact, for papers by K Miyamura Breakdown of academic impact, for papers by Irene Cavattoni Breakdown of academic impact, for papers by Bruce Greig
Rankless by CCL
2026